Form D — Satellos Bioscience Inc.

0001421642-25-000001 · filed Jan 3, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $25,016,264
Reported amount sold: $25,016,264
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Satellos Bioscience Inc.
CIK: 1421642
Entity: Corporation
Jurisdiction: CANADA (FEDERAL LEVEL)
Year incorporated: 2021
Address: ROYAL BANK PLAZA, S. TOWER, 200 BAY ST.
TORONTO, A6 M5J 2J1
Phone: 416-708-0522

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Frank Gleeson · Executive Officer

Toronto, A6 Find on LinkedIn ↗
Michael Rudnicki · Executive Officer

Toronto, A6 Find on LinkedIn ↗
Elizabeth Williams · Executive Officer

Toronto, A6 Find on LinkedIn ↗
Geoff MacKay · Director

Toronto, A6 Find on LinkedIn ↗
Adam Mostafa · Director

Toronto, A6 Find on LinkedIn ↗
Brian Bloom · Director

Toronto, A6 Find on LinkedIn ↗
William McVicar · Director

Toronto, A6 Find on LinkedIn ↗
Bill Jarosz · Director

Toronto, A6 Find on LinkedIn ↗
Rima Al-awar · Director

Toronto, A6 Find on LinkedIn ↗
Michael Robert Cross · Executive Officer

Toronto, A6 Find on LinkedIn ↗
Philip D. Lambert · Executive Officer

Toronto, A6 Find on LinkedIn ↗
Courtney Wells · Executive Officer

Toronto, A6 Find on LinkedIn ↗
Franklin Berger · Director

Toronto, A6 Find on LinkedIn ↗
Stephanie Brown · Director

Toronto, A6 Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗